{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:36:27Z","timestamp":1777296987395,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/1472-6750-3-15","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T06:24:19Z","timestamp":1066112659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii"],"prefix":"10.1186","volume":"3","author":[{"given":"Susanna","family":"Ricci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Boss\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donata","family":"Medaglini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Boraschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,9,17]]},"reference":[{"key":"49_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0169-409X(00)00095-8","volume":"44","author":"ML Hedley","year":"2000","unstructured":"Hedley ML: Gene therapy of chronic inflammatory disease. Adv Drug Deliv Rev. 2000, 44: 195-207. 10.1016\/S0169-409X(00)00095-8.","journal-title":"Adv Drug Deliv Rev"},{"key":"49_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1517\/14712598.1.3.455","volume":"1","author":"MH Holtmann","year":"2001","unstructured":"Holtmann MH, Galle PR, Neurath MF: Immunotherapeutic approaches to inflammatory bowel diseases. Expert Opin Biol Ther. 2001, 1: 455-466.","journal-title":"Expert Opin Biol Ther"},{"key":"49_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/gast.2001.22122","volume":"120","author":"F Shanahan","year":"2001","unstructured":"Shanahan F: Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology. 2001, 120: 622-635.","journal-title":"Gastroenterology"},{"key":"49_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0002-9270(99)00812-6","volume":"95","author":"M Schultz","year":"2000","unstructured":"Schultz M, Sartor RB: Probiotics and inflammatory bowel diseases. Am J Gastroenterol. 2000, 95: 19-21. 10.1016\/S0002-9270(99)00812-6.","journal-title":"Am J Gastroenterol"},{"key":"49_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA: Proinflammatory cytokines. Chest. 2000, 118: 503-508. 10.1378\/chest.118.2.503.","journal-title":"Chest"},{"key":"49_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","volume":"16","author":"WP Arend","year":"1998","unstructured":"Arend WP, Malyak M, Guthridge CJ, Gabay C: Interleukin-1 receptor antagonist: role in biology. Ann Rev Immunol. 1998, 16: 27-55. 10.1146\/annurev.immunol.16.1.27.","journal-title":"Ann Rev Immunol"},{"key":"49_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/08830189809043005","volume":"16","author":"CA Dinarello","year":"1998","unstructured":"Dinarello CA: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 1998, 16: 457-499.","journal-title":"Int Rev Immunol"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/oso\/9780198500438.003.0004","volume-title":"In Pharmacology of cytokines","author":"A Mantovani","year":"2000","unstructured":"Mantovani A, Dinarello CA, Ghezzi P: Interleukin-1 receptor antagonist. In Pharmacology of cytokines. Edited by: Mantovani A, Dinarello CA, Ghezzi P. 2000, Oxford: Oxford University Press, 91-119."},{"key":"49_CR9","volume-title":"Thousand Oaks: Amgen Inc","author":"CA Dinarello","year":"2001","unstructured":"Dinarello CA, Moldawer LL: Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis. A primer for clinicians. Thousand Oaks: Amgen Inc. 2001"},{"key":"49_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/348550a0","volume":"348","author":"K Ohlsson","year":"1990","unstructured":"Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990, 348: 550-552. 10.1038\/348550a0.","journal-title":"Nature"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fasebj.5.3.1825816","volume":"5","author":"G Wakabayashi","year":"1991","unstructured":"Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA: A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 1991, 5: 338-343.","journal-title":"FASEB J"},{"key":"49_CR12","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1073\/pnas.93.20.11008","volume":"93","author":"E Hirsch","year":"1996","unstructured":"Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA. 1996, 93: 11008-11013. 10.1073\/pnas.93.20.11008.","journal-title":"Proc Natl Acad Sci USA"},{"key":"49_CR13","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/diabetes.48.9.1730","volume":"48","author":"N Giannoukakis","year":"1999","unstructured":"Giannoukakis N, Rudert WA, Ghivazzani SC, Gambotto A, Ricordi C, Trucco M, Robbins PD: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1 beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes. 1999, 48: 1730-1736.","journal-title":"Diabetes"},{"key":"49_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0006-8993(96)01277-2","volume":"751","author":"GY Yang","year":"1997","unstructured":"Yang GY, Davidson BL, Betz AL: Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res. 1997, 751: 181-188. 10.1016\/S0006-8993(96)01277-2.","journal-title":"Brain Res"},{"key":"49_CR15","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","volume":"271","author":"CJ Fisher","year":"1994","unstructured":"Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines HD, Shelly MP, Thompson BW, La Brecque JF, Catalano MA, Knaua WA, Sadoff JC: Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994, 271: 1836-1843. 10.1001\/jama.271.23.1836.","journal-title":"JAMA"},{"key":"49_CR16","first-page":"454","volume":"4","author":"BR Krishnan","year":"1999","unstructured":"Krishnan BR: Interleukin-1 receptor antagonist gene therapy for arthritis. Curr Opin Mol Ther. 1999, 4: 454-457.","journal-title":"Curr Opin Mol Ther"},{"key":"49_CR17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/hum.1996.7.10-1261","volume":"7","author":"CH Evans","year":"1996","unstructured":"Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC, Lotze MT, Wright TM: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther. 1996, 7: 1261-1280.","journal-title":"Hum Gene Ther"},{"key":"49_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00832009","volume":"20","author":"C Gabay","year":"1998","unstructured":"Gabay C, Arend WP: Treatment of rheumatoid arthritis with IL-1 inhibitors. Springer Semin Immunopathol. 1998, 20: 229-246. 10.1007\/s002810050032.","journal-title":"Springer Semin Immunopathol"},{"key":"49_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s002689900401","volume":"22","author":"G Rogler","year":"1998","unstructured":"Rogler G, Andus T: Cytokines in inflammatory bowel disease. World J Surg. 1998, 22: 382-389. 10.1007\/s002689900401.","journal-title":"World J Surg"},{"key":"49_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","volume":"115","author":"C Fiocchi","year":"1998","unstructured":"Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998, 115: 182-205.","journal-title":"Gastroenterology"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4049\/jimmunol.154.5.2434","volume":"154","author":"V Casini-Raggi","year":"1995","unstructured":"Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol. 1995, 154: 2434-2440.","journal-title":"J Immunol"},{"key":"49_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1172\/JCI117345","volume":"94","author":"M Ferretti","year":"1994","unstructured":"Ferretti M, Casini-Raggi V, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F: Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest. 1994, 94: 449-453.","journal-title":"J Clin Invest"},{"key":"49_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1046\/j.1365-2249.1998.00595.x","volume":"112","author":"S Dionne","year":"1998","unstructured":"Dionne S, D'Agata ID, Hiscott J, Vanounou T, Seidman EG: Colonic explant production of IL-1 and its receptor antagonist is unbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol. 1998, 112: 435-442. 10.1046\/j.1365-2249.1998.00595.x.","journal-title":"Clin Exp Immunol"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0016-5085(94)90696-3","volume":"106","author":"JC Mansfield","year":"1994","unstructured":"Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 1994, 106: 637-642.","journal-title":"Gastroenterology"},{"key":"49_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0016-5085(99)70338-0","volume":"117","author":"NA Tountas","year":"1999","unstructured":"Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L, Melani L, Pizarro TT, Rotter JI, Cominelli F: Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999, 117: 806-813.","journal-title":"Gastroenterology"},{"key":"49_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1086\/338261","volume":"34","author":"SS Witkin","year":"2002","unstructured":"Witkin SS, Gerber AS, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002, 34: 204-209. 10.1086\/338261.","journal-title":"Clin Infect Dis"},{"key":"49_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-662-07548-7_3","volume-title":"In Gram-positive bacteria. Vaccine vehicles for mucosal immunization","author":"G Pozzi","year":"1997","unstructured":"Pozzi G, Oggioni MR, Medaglini D: Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. In Gram-positive bacteria. Vaccine vehicles for mucosal immunization. Edited by: Pozzi G, Wells JM. 1997, Springer-Verlag (Berlin) and Landes Bioscience (Georgetown, TX), 35-60."},{"key":"49_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/IAI.68.2.760-766.2000","volume":"68","author":"S Ricci","year":"2000","unstructured":"Ricci S, Medaglini D, Rush CM, Marcello A, Manganelli R, Pal\u00f9 G, Pozzi G: Immunogenicity of the B monomer of the Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii. Infect Immun. 2000, 68: 760-766. 10.1128\/IAI.68.2.760-766.2000.","journal-title":"Infect Immun"},{"key":"49_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/80250","volume":"18","author":"C Beninati","year":"2000","unstructured":"Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L: Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol. 2000, 18: 1060-1064. 10.1038\/80250.","journal-title":"Nat Biotechnol"},{"key":"49_CR30","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/00002030-200207050-00006","volume":"16","author":"B Giomarelli","year":"2002","unstructured":"Giomarelli B, Provvedi R, Meacci F, Maggi T, Medaglini D, Pozzi G, Mori T, McMahon JB, Gardella RS, Boyd MR: The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. AIDS. 2002, 16: 1351-1356. 10.1097\/00002030-200207050-00006.","journal-title":"AIDS"},{"key":"49_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0378-1119(95)00775-X","volume":"169","author":"MR Oggioni","year":"1996","unstructured":"Oggioni MR, Pozzi G: A host-vector system for heterologous gene expression in Streptococcus gordonii. Gene. 1996, 169: 85-90. 10.1016\/0378-1119(95)00775-X.","journal-title":"Gene"},{"key":"49_CR32","first-page":"263","volume-title":"In DNA Transfer and Gene Expression in Microorganisms","author":"D Medaglini","year":"1993","unstructured":"Medaglini D, Oggioni MR, Contorni M, Cavalieri F, Pozzi G: Secretion of heterologous proteins in Streptococcus gordonii (Streptococcus sanguis) Challis. In DNA Transfer and Gene Expression in Microorganisms. Edited by: Balla E, Berencsi G, Szentirmai A. 1993, Andover: Intercept Ltd, 263-268."},{"key":"49_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/0923-2508(90)90060-4","volume":"141","author":"G Pozzi","year":"1990","unstructured":"Pozzi G, Musmanno RA, Lievens PMJ, Oggioni MR, Plevani P, Manganelli R: Methods and parameters for genetic transformation of Streptococcus sanguis Challis. Res Microbiol. 1990, 141: 659-670. 10.1016\/0923-2508(90)90060-4.","journal-title":"Res Microbiol"},{"key":"49_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1600-0897.1998.tb00354.x","volume":"39","author":"D Medaglini","year":"1998","unstructured":"Medaglini D, Oggioni MR, Pozzi G: Vaginal immunization with recombinant Gram positive bacteria. Am J Reprod Immunol. 1998, 39: 199-208.","journal-title":"Am J Reprod Immunol"},{"key":"49_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","volume":"75","author":"B Sadlack","year":"1993","unstructured":"Sadlack B, Hartmut M, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with disrupted interleukin-2 gene. Cell. 1993, 75: 253-261.","journal-title":"Cell"},{"key":"49_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-065X.1995.tb00092.x","volume":"148","author":"I Horak","year":"1995","unstructured":"Horak I, Lohler J, Ma A, Smith KA: Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev. 1995, 148: 35-44.","journal-title":"Immunol Rev"},{"key":"49_CR37","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1006\/cyto.2000.0716","volume":"12","author":"WJ de Villiers","year":"2000","unstructured":"de Villiers WJ, Varilek GW, de Beer FC, Guo JT, Kindy MS: Increased serum amyloid A levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine. 2000, 12: 1337-1347. 10.1006\/cyto.2000.0716.","journal-title":"Cytokine"},{"key":"49_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/gut.41.6.793","volume":"41","author":"IB Autenrieth","year":"1997","unstructured":"Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I: Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with inflammatory bowel disease. Gut. 1997, 41: 793-800.","journal-title":"Gut"},{"key":"49_CR39","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/art.1780390914","volume":"39","author":"JP Caron","year":"1996","unstructured":"Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier J-P: Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 1996, 39: 1535-1544.","journal-title":"Arthritis Rheum"},{"key":"49_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1073\/pnas.93.1.402","volume":"93","author":"SS Makarov","year":"1996","unstructured":"Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS, Haskill JS, Schwab JH: Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA. 1996, 93: 402-406. 10.1073\/pnas.93.1.402.","journal-title":"Proc Natl Acad Sci USA"},{"key":"49_CR41","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.158.7.3492","volume":"158","author":"U Muller-Ladner","year":"1997","unstructured":"Muller-Ladner U, Roberts CRFBN, Gay RE, Robbins PD, Evans CH, Gay S: Human IL-1ra gene transfer into human synovial fibroblast is chondroprotective. J Immunol. 1997, 158: 3492-3498.","journal-title":"J Immunol"},{"key":"49_CR42","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/art.1780400604","volume":"40","author":"JP Pelletier","year":"1997","unstructured":"Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, Fernandes JC, Martel-Pelletier J: In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 1997, 40: 1012-1019.","journal-title":"Arthritis Rheum"},{"key":"49_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0889-857X(05)70071-5","volume":"25","author":"CH Evans","year":"1999","unstructured":"Evans CH, Robbins PD: Potential treatment of osteoarthritis by gene therapy. Rheum Dis Clin North Am. 1999, 25: 333-344.","journal-title":"Rheum Dis Clin North Am"},{"key":"49_CR44","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1128\/IAI.66.7.3183-3189.1998","volume":"66","author":"L Steidler","year":"1998","unstructured":"Steidler L, Robinson K, Chamberlain LM, Schofield KM, Remaut E, Le Page RWF, Wells JM: Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun. 1998, 66: 3183-3189.","journal-title":"Infect Immun"},{"key":"49_CR45","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"L Steidler","year":"2000","unstructured":"Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000, 289: 1352-1355. 10.1126\/science.289.5483.1352.","journal-title":"Science"},{"key":"49_CR46","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nbt0702-702","volume":"20","author":"C Kruger","year":"2002","unstructured":"Kruger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, Van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, Van Dollenweerd C, Ma JKC, Hammarstrom L: In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol. 2002, 20: 702-706. 10.1038\/nbt0702-702.","journal-title":"Nat Biotechnol"},{"key":"49_CR47","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1128\/IAI.71.4.1887-1896.2003","volume":"71","author":"LG Bermudez-Humaran","year":"2003","unstructured":"Bermudez-Humaran LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de Oca-Luna R, Le Loir Y: Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun. 2003, 71: 1887-1896. 10.1128\/IAI.71.4.1887-1896.2003.","journal-title":"Infect Immun"},{"key":"49_CR48","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1089\/107999099313000","volume":"19","author":"T Takii","year":"1999","unstructured":"Takii T, Honda H, Sasayama S, Kobayashi T, Ikezawa H, Udaka S, Oomoto Y, Onozaki K: Human interleukin-1 receptor antagonist: large-scale expression in Bacillus brevis 47-5Q. J Interferon Citokine Res. 1999, 19: 1325-1331. 10.1089\/107999099313000.","journal-title":"J Interferon Citokine Res"},{"key":"49_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-1656(98)00111-4","volume":"64","author":"D Zanette","year":"1998","unstructured":"Zanette D, Dundon W, Soffientini A, Sottani C, Marinelli F, Akeson A, Sarubbi E: Human IL-1 receptor antagonist from Escherichia coli : large-scale microbial growth and protein purification. J Biotechnol. 1998, 64: 187-196. 10.1016\/S0168-1656(98)00111-4.","journal-title":"J Biotechnol"},{"key":"49_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nbt840","volume":"21","author":"L Steidler","year":"2003","unstructured":"Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E: Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol. 2003, 21: 785-789. 10.1038\/nbt840.","journal-title":"Nat Biotechnol"},{"key":"49_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1574-6968.2002.tb11172.x","volume":"210","author":"T Maggi","year":"2002","unstructured":"Maggi T, Spinosa MR, Ricci S, Medaglini D, Pozzi G, Oggioni MR: Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface. FEMS Microbiol Lett. 2002, 210: 135-141. 10.1016\/S0378-1097(02)00610-9.","journal-title":"FEMS Microbiol Lett"},{"key":"49_CR52","first-page":"1852","volume":"147","author":"P Boss\u00f9","year":"1995","unstructured":"Boss\u00f9 P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G, Del Grosso E, Tagliabue A, Boraschi D: Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol. 1995, 147: 1852-1861.","journal-title":"Am J Pathol"},{"key":"49_CR53","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.4049\/jimmunol.155.10.4719","volume":"155","author":"D Boraschi","year":"1995","unstructured":"Boraschi D, Boss\u00f9 P, Ruggiero P, Tagliabue A, Bertini R, Macchia G, Gasbarro G, Pellegrini L, Melillo G, Ulisse E, Visconti U, Bizzarri C, Del Grosso E, Mackay AR, Frascotti G, Frigerio F, Grifantini R, Grandi G: Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra like domains. J Immunol. 1995, 155: 4719-4725.","journal-title":"J Immunol"},{"key":"49_CR54","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4049\/jimmunol.147.5.1561","volume":"147","author":"A Stoppacciaro","year":"1991","unstructured":"Stoppacciaro A, Boss\u00f9 P, Ghiara P, Ruco LP, Censini S, Scapigliati G, Nuti S, Tagliabue A, Baroni CD, Boraschi D: Binding of IL-1 beta to IL-1R type II at single cell level. J Immunol. 1991, 147: 1561-1566.","journal-title":"J Immunol"},{"key":"49_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-1759(91)90286-O","volume":"142","author":"S Poole","year":"1991","unstructured":"Poole S, Gaines Das RE: The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study. J Immunol Methods. 1991, 142: 1-13. 10.1016\/0022-1759(91)90286-O.","journal-title":"J Immunol Methods"},{"key":"49_CR56","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.158.8.3881","volume":"158","author":"P Ruggiero","year":"1997","unstructured":"Ruggiero P, Boss\u00f9 P, Macchia G, Del Grosso E, Sabbatini V, Bertini R, Colagrande A, Bizzarri C, Maurizi G, Di Cioccio V, D'Andrea G, Di Giulio A, Frigerio F, Grifantini R, Grandi G, Tagliabue A, Boraschi D: Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II. J Immunol. 1997, 158: 3881-3887.","journal-title":"J Immunol"},{"key":"49_CR57","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0264-410X(97)00026-1","volume":"15","author":"D Medaglini","year":"1997","unstructured":"Medaglini D, Rush CM, Sestini P, Pozzi G: Commensal bacteria as vehicles for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci includes local and systemic antibodies in mice. Vaccine. 1997, 15: 1330-1337. 10.1016\/S0264-410X(97)00026-1.","journal-title":"Vaccine"},{"key":"49_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/352621a0","volume":"352","author":"H Schorle","year":"1991","unstructured":"Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 1991, 352: 621-624. 10.1038\/352621a0.","journal-title":"Nature"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6750-3-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:09:51Z","timestamp":1726243791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/1472-6750-3-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,17]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1186\/1472-6750-3-15","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,17]]},"assertion":[{"value":"22 May 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}